![JPM | Free Full-Text | The Potential of Hsp90 in Targeting Pathological Pathways in Cardiac Diseases JPM | Free Full-Text | The Potential of Hsp90 in Targeting Pathological Pathways in Cardiac Diseases](https://www.mdpi.com/jpm/jpm-11-01373/article_deploy/html/images/jpm-11-01373-g001-550.jpg)
JPM | Free Full-Text | The Potential of Hsp90 in Targeting Pathological Pathways in Cardiac Diseases
![Developmental cell death of cortical projection neurons is controlled by a Bcl11a/Bcl6‐dependent pathway | EMBO reports Developmental cell death of cortical projection neurons is controlled by a Bcl11a/Bcl6‐dependent pathway | EMBO reports](https://www.embopress.org/cms/asset/b40fab65-3b39-4d0b-83ec-dc2210563737/embr202154104-abs-0001-m.jpg)
Developmental cell death of cortical projection neurons is controlled by a Bcl11a/Bcl6‐dependent pathway | EMBO reports
![FX1, a BCL6 inhibitor, reactivates BCL6 target genes and suppresses HTLV-1-infected T cells | SpringerLink FX1, a BCL6 inhibitor, reactivates BCL6 target genes and suppresses HTLV-1-infected T cells | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10637-021-01196-1/MediaObjects/10637_2021_1196_Fig3_HTML.png)
FX1, a BCL6 inhibitor, reactivates BCL6 target genes and suppresses HTLV-1-infected T cells | SpringerLink
The sensitivity to Hsp90 inhibitors of both normal and oncogenically transformed cells is determined by the equilibrium between cellular quiescence and activity | PLOS ONE
![Covalent Small Molecule Immunomodulators Targeting the Protease Active Site | Journal of Medicinal Chemistry Covalent Small Molecule Immunomodulators Targeting the Protease Active Site | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.1c00172/asset/images/large/jm1c00172_0014.jpeg)
Covalent Small Molecule Immunomodulators Targeting the Protease Active Site | Journal of Medicinal Chemistry
![Molecules | Free Full-Text | Signaling Pathways and Natural Compounds in Triple-Negative Breast Cancer Cell Line Molecules | Free Full-Text | Signaling Pathways and Natural Compounds in Triple-Negative Breast Cancer Cell Line](https://pub.mdpi-res.com/molecules/molecules-27-03661/article_deploy/html/images/molecules-27-03661-ag.png?1654659571)
Molecules | Free Full-Text | Signaling Pathways and Natural Compounds in Triple-Negative Breast Cancer Cell Line
![Molecular pathogenesis of germinal center‐derived B cell lymphomas - Pasqualucci - 2019 - Immunological Reviews - Wiley Online Library Molecular pathogenesis of germinal center‐derived B cell lymphomas - Pasqualucci - 2019 - Immunological Reviews - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/cf76ead5-d434-4704-b788-5796423ccb8b/imr12745-fig-0005-m.jpg)
Molecular pathogenesis of germinal center‐derived B cell lymphomas - Pasqualucci - 2019 - Immunological Reviews - Wiley Online Library
Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumor | PLOS ONE
![The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing | Nature Cancer The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing | Nature Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs43018-020-0080-0/MediaObjects/43018_2020_80_Fig1_HTML.png)
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing | Nature Cancer
Non è bellissimo questo abitino?😍 In sconto al 50% 🥳 Baby 3-24mesi👶🏼 | By Cycleband Misilmeri | Facebook
![Inhibition of the HIF-1 Survival Pathway as a Strategy to Augment Photodynamic Therapy Efficacy | SpringerLink Inhibition of the HIF-1 Survival Pathway as a Strategy to Augment Photodynamic Therapy Efficacy | SpringerLink](https://media.springernature.com/lw685/springer-static/image/chp%3A10.1007%2F978-1-0716-2099-1_19/MediaObjects/453861_1_En_19_Fig4_HTML.png)
Inhibition of the HIF-1 Survival Pathway as a Strategy to Augment Photodynamic Therapy Efficacy | SpringerLink
![Frontiers | System-Level Scenarios for the Elucidation of T Cell-Mediated Germinal Center B Cell Differentiation Frontiers | System-Level Scenarios for the Elucidation of T Cell-Mediated Germinal Center B Cell Differentiation](https://www.frontiersin.org/files/Articles/734282/fimmu-12-734282-HTML-r1/image_m/fimmu-12-734282-g001.jpg)
Frontiers | System-Level Scenarios for the Elucidation of T Cell-Mediated Germinal Center B Cell Differentiation
![IJMS | Free Full-Text | Uncovering Oncogenic Mechanisms of Tumor Suppressor Genes in Breast Cancer Multi-Omics Data IJMS | Free Full-Text | Uncovering Oncogenic Mechanisms of Tumor Suppressor Genes in Breast Cancer Multi-Omics Data](https://pub.mdpi-res.com/ijms/ijms-23-09624/article_deploy/html/images/ijms-23-09624-g001.png?1661418759)
IJMS | Free Full-Text | Uncovering Oncogenic Mechanisms of Tumor Suppressor Genes in Breast Cancer Multi-Omics Data
B-cell Lymphoma 6 Inhibitors: Current Advances and Prospects of Drug Development for Diffuse Large B-cell Lymphomas | Journal of Medicinal Chemistry
![THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors | Nature Communications THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fncomms14290/MediaObjects/41467_2017_Article_BFncomms14290_Fig1_HTML.jpg)
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors | Nature Communications
![Human positive coactivator 4 is a potential novel therapeutic target in non-small cell lung cancer | Cancer Gene Therapy Human positive coactivator 4 is a potential novel therapeutic target in non-small cell lung cancer | Cancer Gene Therapy](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fcgt.2012.52/MediaObjects/41417_2012_Article_BFcgt201252_Fig3_HTML.jpg)